Join the Columbian College Department of Chemistry for an event featuring Heather Murrey, PhD, Senior Director of Chemical Biology at Scorpion Therapeutics. Murrey will discuss chemical biology approaches to advancing covalent ligand drug discovery for precision oncology medicines. 

About the Speaker

Scorpion Therapeutics is a precision oncology company. Prior to joining Scorpion, Dr. Murrey worked at Janssen, where she supported covalent inhibitor development using novel chemical biology and chemoproteomics assays. completed her PhD in Biochemistry and Molecular Biophysics at the California Institute of Technology working with Professor Linda Hsieh-Wilson, where her work focused on exploring bioorthogonal tool compounds to characterize neuronal glycans involved in neuronal signaling. She was a postdoctoral fellow at the Scripps Research Institute with Professor Benjamin Cravatt followed by Pfizer (Cambridge, MA) where her work enabled characterization of inhibitor mechanism-of-action. More information can be found on the GW Department of Chemistry website.